Bain Capital Public Equity Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,262,328
Closed -$9.23M 12
2019
Q1
$9.23M Buy
1,262,328
+355,662
+39% +$3.48M 0.88% 29
2018
Q4
$8.3M Buy
+906,666
New +$10M 0.78% 32
2018
Q3
Sell
-275,262
Closed -$4.2M 71
2018
Q2
$4.2M Buy
+275,262
New +$4.76M 0.28% 46
2018
Q1
Sell
-249,052
Closed -$4.66M 76
2017
Q4
$4.66M Buy
+249,052
New +$5M 0.34% 51
2017
Q3
Sell
-491,300
Closed -$4.74M 69
2017
Q2
$4.74M Buy
+491,300
New +$3.19M 0.29% 43
2014
Q3
Sell
-527,494
Closed -$8.44M 55
2014
Q2
$8.44M Sell
527,494
-187,510
-26% -$2.83M 0.2% 55
2014
Q1
$12.9M Sell
715,004
-84,996
-11% -$1.58M 0.34% 44
2013
Q4
$15.7M Buy
+800,000
New +$11.7M 0.44% 38

Other funds holding DVAX

Bain Capital Public Equity Management's DVAX Position: Q2 2019 in Review

Bain Capital Public Equity Management sold out of Dynavax Technologies (DVAX) in Q2 2019, closing a stake of 1,262,328 shares — an estimated $9.23M sold.

Bain Capital Public Equity Management first reported a position in DVAX in Q4 2013 and held it in 8 quarters. The position peaked at $15.7M in Q4 2013. 127 funds tracked by Wall St. Rank hold DVAX as of Q2 2019.

  • Bain Capital Public Equity Management reported no remaining Dynavax Technologies position as of Q2 2019 after selling out during the quarter.
  • Bain Capital Public Equity Management sold 1,262,328 Dynavax Technologies shares in Q2 2019, an estimated $9.23M.
  • Bain Capital Public Equity Management first reported a position in Dynavax Technologies in Q4 2013 and held it in 8 quarters.
  • Bain Capital Public Equity Management's Dynavax Technologies position peaked at $15.7M in Q4 2013.
  • 127 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2019.

Based on Bain Capital Public Equity Management's 13F filing for Q2 2019.